Year archive

ISLAND PHARMACEUTICALS LIMITED — 2023 filings

All 40 regulatory filings released by ISLAND PHARMACEUTICALS LIMITED (ILA) in 2023, sourced directly from the official regulator.

40 Filings

2023 Period

2023 filings (40)

Filing	Released	Lang
Approval to commence dosing 3rd cohort of ISLA-101 SAD study 2 pages 160.7KB Regulatory Filings	2023-12-21	English
R&D Tax Incentive loan facility secured with Radium Capital 2 pages 159.1KB Capital/Financing Update	2023-12-14	English
Second cohort dosed in ISLA-101 Single Ascending Dose study 2 pages 118.0KB Regulatory Filings	2023-12-11	English
Company Secretary Appointment/Resignation 2 pages 108.5KB Board/Management Information	2023-11-30	English
Island doses first cohort in ISLA-101 clinical trial 2 pages 130.3KB Capital/Financing Update	2023-11-23	English
Annual General Meeting MD Presentation 24 pages 2.0MB Investor Presentation	2023-11-15	English
Results of AGM 2 pages 109.0KB Declaration of Voting Results & Voting Rights Announcements	2023-11-15	English
Replacement - Results of AGM 2 pages 123.9KB Declaration of Voting Results & Voting Rights Announcements	2023-11-15	English
Replacement Constitution 57 pages 774.1KB Governance Information	2023-11-15	English
Screening commences for ISLA-101 Single Ascending Dose Study 2 pages 126.4KB Regulatory Filings	2023-11-12	English
Island receives R&D tax refund for FY2023 1 page 12 Regulatory Filings	2023-11-09	English
Island receives ethics approval for ISLA-101 study 2 pages 131.9KB Regulatory Filings	2023-11-06	English
ILA releases updated investor presentation 25 pages 2.1MB Investor Presentation	2023-11-05	English
ILA granted key Australian patent for ISLA-101 2 pages 131.1KB Regulatory Filings	2023-11-01	English
Island Annual General Meeting online link for shareholders 2 pages 106.1KB AGM Information	2023-10-30	English
Quarterly Activity Report & Appendix 4C 7 pages 339.3KB Interim / Quarterly Report	2023-10-29	English
Letter to Shareholders, Notice of AGM & Proxy Form 113 pages 1.8MB AGM Information	2023-10-12	English
Annual Report to Shareholders 60 pages 4.4MB Regulatory Filings	2023-10-12	English
Date of AGM & Closing Date for Director Nominations 1 AGM Information	2023-09-25	English
ISLA-101 Single Ascending Dose study update 3 pages 204.6KB Capital/Financing Update	2023-09-24	English
Island Pharmaceuticals granted key U.S. patent for ISLA-101 2 pages 132.9KB Regulatory Filings	2023-09-12	English
Appendix 4E & Annual Report 62 pages 4.5MB Regulatory Filings	2023-08-29	English
Corporate Governance Statement 13 pages 427.0KB Governance Information	2023-08-29	English
Appendix 4G 14 pages 407.0KB Regulatory Filings	2023-08-29	English
Quarterly Activity Report & Appendix 4C 8 pages 339.9KB Interim / Quarterly Report	2023-07-30	English
US grant funding to support ISLA-101 clinical development 2 pages 121.0KB Capital/Financing Update	2023-07-06	English
Island receives FDA go-ahead for ISLA-101 program 2 pages 95.2KB Capital/Financing Update	2023-05-15	English
Quarterly Activity Report & Appendix 4C 8 pages 253.7KB Interim / Quarterly Report	2023-04-26	English
Change in substantial holding 3 pages 182.5KB Major Shareholding Notification	2023-04-26	English
Replacement - Change in substantial holding 3 pages 182.2KB Major Shareholding Notification	2023-04-26	English
Island submits responses to FDA questions for ISLA-101 2 pages 79.0KB Regulatory Filings	2023-04-16	English
Application for quotation of securities - ILA 6 pages 27.2KB Share Issue/Capital Change	2023-04-12	English
Notification of cessation of securities - ILA 4 pages 24.9KB Share Issue/Capital Change	2023-04-03	English
Appendix 3Y - Albert Hansen 2 pages 285.4KB Director's Dealing	2023-04-03	English
Release of Securities from Escrow 1 page 73.3KB Regulatory Filings	2023-04-02	English
Appendix 4D & Half-Year Financial Statements 19 pages 623.0KB Interim / Quarterly Report	2023-02-22	English
Change in substantial holding 3 pages 184.7KB Major Shareholding Notification	2023-02-06	English
ILA receives additional FDA feedback on IND for ISLA 101 2 pages 100.7KB Regulatory Filings	2023-01-31	English
Quarterly Activity Report & Appendix 4C 9 pages 312.8KB Interim / Quarterly Report	2023-01-29	English
Island receives FDA feedback on Phase 2a clinical study 2 pages 99.2KB Regulatory Filings	2023-01-19	English